Form 8-K - Current report:
SEC Accession No. 0001437749-25-026043
Filing Date
2025-08-12
Accepted
2025-08-12 08:01:13
Documents
15
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20250807_8k.htm   iXBRL 8-K 25482
2 EXHIBIT 99.1 ex_849537.htm EX-99.1 15122
7 ex_849537img001.jpg GRAPHIC 3407
  Complete submission text file 0001437749-25-026043.txt   183555

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20250812.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20250812_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20250812_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20250812_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20250807_8k_htm.xml XML 2955
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 251204106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)